
Protalix Bio Therapeutics Inc. (PLX) Rebounds Following Insider Transaction
On Wednesday, an SEC filing was revealed regarding the insider transaction of Protalix Bio Therapeutics Inc. (PLX) stock. The company’s CEO acquired some shares of
On Wednesday, an SEC filing was revealed regarding the insider transaction of Protalix Bio Therapeutics Inc. (PLX) stock. The company’s CEO acquired some shares of
Biofrontera Inc. (BFRI) shares soared high on April 13, as its Germany lab got approval from FDA for testing skin disease therapy Ameluz®. But the
In a transaction on April 13, 2022, major shareholder Braden Michael Leonard acquired further shares of Gemini Therapeutics Inc. (GMTX). Disclosed in an SEC filing
After being in the red for over a week, the gene therapy company, Adverum Biotechnologies Inc. (ADVM) became bullish on Wednesday. Gaining only 1.72% in
The development stage biopharma, Artelo Biosceinces Inc. (ARTL) was trending on April 13, due to positive results from its lead program in cancer-related Cachexia. The
Stocks under $5 can be a good choice for low-budget investors, especially as the new year begins. These stocks are also known as penny stocks.
The online and offline education services provider, Genius Group Ltd. (GNS) made its public debut yesterday, April 12, 2022. Despite certain red flags regarding the
Sonnet Bio Therapeutics Holdings Inc. (SONN) had a bullish day on April 12, 2022, with gains spreading over both the regular and after-hours sessions. The
The clinical-stage healthcare company, Kaleido Biosciences Inc. (KLDO) announced ceasing operations altogether on Friday. The company’s SEC filing revealed plans to wind down operations, total
Shares of Histogen Inc. (HSTO) exploded on April 12, during the regular trading session. The stock peaked at $0.4161 to add 67.78% at the close
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.